1. Home
  2. GBCI vs GKOS Comparison

GBCI vs GKOS Comparison

Compare GBCI & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glacier Bancorp Inc.

GBCI

Glacier Bancorp Inc.

N/A

Current Price

$49.11

Market Cap

6.3B

Sector

Finance

ML Signal

N/A

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$141.38

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GBCI
GKOS
Founded
1955
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.0B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
GBCI
GKOS
Price
$49.11
$141.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
12
Target Price
$54.00
$126.92
AVG Volume (30 Days)
769.5K
679.9K
Earning Date
04-23-2026
04-29-2026
Dividend Yield
2.74%
N/A
EPS Growth
18.45
N/A
EPS
0.63
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
$31.52
$23.32
Revenue Next Year
$8.46
$27.43
P/E Ratio
$24.65
N/A
Revenue Growth
N/A
32.33
52 Week Low
$39.90
$73.16
52 Week High
$53.99
$146.75

Technical Indicators

Market Signals
Indicator
GBCI
GKOS
Relative Strength Index (RSI) 56.61 69.99
Support Level $47.16 $80.14
Resistance Level $50.20 N/A
Average True Range (ATR) 1.12 4.92
MACD -0.06 1.86
Stochastic Oscillator 57.51 79.44

Price Performance

Historical Comparison
GBCI
GKOS

About GBCI Glacier Bancorp Inc.

Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: